The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Cytochrome P450 and Vascular Homeostasis
Abstract
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expressed within the cardiovascular system play a crucial role in the modulation of vascular homeostasis. There is strong evidence suggesting that the activation of a CYP epoxygenase in endothelial cells is an essential step in nitric oxide and prostacyclin-independent vasodilatation of several vascular beds, particularly in the heart and kidney. A smooth muscle CYP ω-hydroxylase, on the other hand, generates a vasoconstrictor eicosanoid that is central to the myogenic response. Moreover, CYP epoxygenase and ω-hydroxylase products, as well as CYP-derived reactive oxygen species, are intracellular signal transduction molecules involved in several signaling cascades affecting numerous cellular processes, including vascular cell proliferation and angiogenesis. This review summarizes the vascular effects of epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid, both of which are CYP-derived metabolites of arachidonic acid, endogenously generated within endothelial and vascular smooth muscle cells. Although the link between CYP expression/activity and cardiovascular disease is currently tentative, the evidence being accumulated to suggest that CYP pathways are altered in animal models of hypertension and atherosclerosis can no longer be ignored. The development of selective pharmacological tools is, however, a prerequisite for the analysis of the involvement of specific CYP isoforms in the regulation of vascular homeostasis in human subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of these proteins in endothelial cells makes them a significant source of superoxide in the vasculature (295, 298).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,663
Signal Transduction through MAP Kinase Cascades
Lewis, T. S., Shapiro, P. S., & Ahn, N. G. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
On the local reactions of the arterial wall to changes of internal pressure
Bayliss, W. M. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000911 · Cited by 1,526
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X.-L., Yang, B., Spiecker, M., Ley, K. F., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,218
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fißlthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Self-citationGuengerich, F. P. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_14 · Cited by 732
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 598
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 559
Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 506
Research works printed but not linked: 24
- 10.1161/hyp.25.4.854 · DOI
- 10.1161/res.81.2.258 · DOI
- 10.1161/res.83.5.501 · DOI
- 10.1161/circ.103.15.1992 · DOI
- 10.1161/res.78.3.415 · DOI
- 10.1161/circ.99.24.3132 · DOI
- 10.1161/res.88.1.44 · DOI
- 10.1161/circ.94.12.3341 · DOI
- 10.1161/str.28.5.1066 · DOI
- 10.1161/res.66.3.2306810 · DOI
- 10.1161/hyp.37.3.887 · DOI
- 10.1161/hyp.29.1.320 · DOI
- 10.1161/res.83.11.1069 · DOI
- 10.1161/str.27.5.971 · DOI
- 10.1161/res.82.6.696 · DOI
- 10.1161/res.81.5.797 · DOI
- 10.1161/circ.96.10.3610 · DOI
- 10.1161/res.85.4.349 · DOI
- 10.1161/res.80.6.877 · DOI
- 10.1161/hyp.31.1.242 · DOI
- 10.1161/hyp.33.1.408 · DOI
- 10.1161/circ.100.13.1400 · DOI
- 10.1161/res.79.4.784 · DOI
- 10.1161/res.87.11.992 · DOI
Cited by
Sorted by citations
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
Watanabe, H., Vriens, J., Prenen, J., Droogmans, G., Voets, T., & Nilius, B. (2003) · Nature · doi:10.1038/nature01807 · Cited by 1,030
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Li, J.-M., & Shah, A. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2004 · Cited by 773
Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling
Metea, M. R., & Newman, E. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4048-05.2006 · Cited by 637
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Allimuthu, D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01243 · Cited by 587
Mechanisms that regulate production of reactive oxygen species by cytochrome P450
Zangar, R. C. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.018 · Cited by 555
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
TRPV4 calcium entry channel: a paradigm for gating diversity
Nilius, B., Vriens, J., Prenen, J., Droogmans, G., & Voets, T. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00365.2003 · Cited by 492
EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological Roles
Morisseau, C. H. P., & Hammock, B. D. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095920 · Cited by 482
Action of epoxyeicosatrienoic acids on cellular function
Spector, A. A., & Norris, A. W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2006 · Cited by 487
Epoxide hydrolases: their roles and interactions with lipid metabolism
Newman, J. W. I., Morisseau, C. H. P., & Hammock, B. D. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.10.001 · Cited by 476
REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
Aitken, A. E., Richardson, T. A., & Morgan, E. T. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141059 · Cited by 449
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_7 · Cited by 419
Vriens, J., Owsianik, G., Fißlthaler, B., Suzuki, M., Janssens, A., Voets, T., Morisseau, C. H. P., Hammock, B. D., Fleming, I., Busse, R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000187474.47805.30 · Cited by 365
Self-citationEpoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology
Imig, J. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00021.2011 · Cited by 363
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P. H., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 339
Astrocyte control of the cerebrovasculature
Gordon, G. R., Mulligan, S. J., & MacVicar, B. A. (2007) · Glia · doi:10.1002/glia.20543 · Cited by 339
Kunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302
Macrophage Differentiation to Foam Cells
Shashkin, P. N., Dragulev, B. P., & Ley, K. F. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054865064 · Cited by 296
Jiang, J.-G., Chun-lian, C. H. E. N., Card, J. W., Yang, S., Chen, J.-X., Fu, X.-N., Ning, Y.-G., Xiao, X., Zeldin, D. C., & Wang, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4173 · Cited by 284
Nitric oxide, oxidative stress, and progression of chronic renal failure
Modlinger, P., Wilcox, C. S., & Aslam, S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.04.007 · Cited by 282
NADPH oxidase and endothelial cell function
Ray, R., & Shah, A. M. (2005) · Clinical Science · doi:10.1042/cs20050067 · Cited by 280
Bivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02743.x · Cited by 266
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
Miyata, N., & Roman, R. J. (2005) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.41.175 · Cited by 239
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Xu, D., Li, N., He, Y., Timofeyev, V., Lü, L., Tsai, H.-J., Kim, I.-H., Tuteja, D., Mateo, R. K. P., Singapuri, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609158103 · Cited by 235
Griffith, T. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705698 · Cited by 234
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Imig, J. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00350.2004 · Cited by 232
Wang, Y., Wei, X., Xiao, X., Hui, R., Card, J. W., Carey, M. A., Wang, D. W., & Zeldin, D. C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083477 · Cited by 205
Cytochrome P450 pathways of arachidonic acid metabolism
Kroetz, D. L., & Zeldin, D. C. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00007 · Cited by 193
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
Zhang, G., Kodani, S. D., & Hammock, B. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.11.003 · Cited by 193
Gomez, G. A., Morisseau, C. H. P., Hammock, B. D., & Christianson, D. W. (2004) · Biochemistry · doi:10.1021/bi036189j · Cited by 187
The contribution of astrocytes to the regulation of cerebral blood flow
Howarth, C. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00103 · Cited by 187
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Zhang, J., Duan, D., Song, Z., Liu, T., Hou, Y., & Fang, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21734 · Cited by 184
Chuang, S. S., Helvig, C. F., Taimi, M., Ramshaw, H., Collop, A. H., Amad, M., White, J. A., Petkovich, M. P., Jones, G., & Korczak, B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311830200 · Cited by 181
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension
Jung, O., Brandes, R. P., Kim, I.-H., Schweda, F., Schmidt, R., Hammock, B. D., Busse, R., & Fleming, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000153792.29478.1d · Cited by 180
Self-citationThe Soluble Epoxide Hydrolase as a Pharmaceutical Target for Hypertension
Chiamvimonvat, N., Ho, C.-M., Tsai, H.-J., & Hammock, B. D. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181506445 · Cited by 177
Michaelis, U. R., Fißlthaler, B., Barbosa‐Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02674 · Cited by 173
Self-citationSun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., & Liao, J. K. (2002) · Circulation Research · doi:10.1161/01.res.0000017727.35930.33 · Cited by 171
Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies
Jones, P. D., Wolf, N. M., Morisseau, C. H. P., Whetstone, P. A., Hock, B., & Hammock, B. D. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.041 · Cited by 169
Michaelis, U. R., Fißlthaler, B., Medhora, M. M., Harder, D. R., Fleming, I., & Busse, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0640fje · Cited by 169
Self-citationReduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors
Granville, D. J., Tashakkor, B., Takeuchi, C., Gustafsson, Å. B., Huang, C., Sayen, M. R., Wentworth, P., Yeager, M., & Gottlieb, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308185100 · Cited by 167
Dhanasekaran, A., Gruenloh, S. K., Buonaccorsi, J. N., Zhang, R., Gross, G. J., Falck, J. R., Patel, P. K., Jacobs, E. R., & Medhora, M. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00979.2007 · Cited by 168
Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular Tissues
DeLozier, T. C., Kissling, G. E., Coulter, S. J., Dai, D., Foley, J. F., Bradbury, J. A., Murphy, E., Steenbergen, C., Zeldin, D. C., & Goldstein, J. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012823 · Cited by 163
Potente, M., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305385200 · Cited by 155
Self-citationSuematsu, M., Suzuki, H., DeLano, F. A., & Schmid‐Schönbein, G. W. (2002) · Microcirculation · doi:10.1038/sj.mn.7800141 · Cited by 155
Mammalian cytochromes P450—Importance of tissue specificity
Seliškar, M., & Rozman, D. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.016 · Cited by 154
Liu, Y., Terata, K., Chai, Q., Li, H., Kleinman, L. H., & Gutterman, D. D. (2002) · Circulation Research · doi:10.1161/01.res.0000046003.14031.98 · Cited by 154
Seet, R. C. S., Lee, J. C., Loke, W. M., Huang, S. H., Huang, H.-W., Looi, W. F., Chew, S. E., Quek, A. M. L., Lim, E. C. H., & Halliwell, B. B. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.019 · Cited by 152
Ward, N. C., Tsai, I.-J., Barden, A. E., BOCKXMEER, F. M. V., Puddey, I. B., Hodgson, J. M., & Croft, K. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104463 · Cited by 149
Cytochrome P450 epoxygenases as EDHF synthase(s)
Fleming, I. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.016 · Cited by 145
Self-citationSchwarz, D., Kisselev, P., Ericksen, S. S., Szklarz, G. D., Chernogolov, A. A., Honeck, H., Schunck, W., & Roots, I. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.023 · Cited by 142
Fichtlscherer, S., Dimmeler, S., Breuer, S., Busse, R., Zeiher, A. M., & Fleming, I. (2003) · Circulation · doi:10.1161/01.cir.0000105763.51286.7f · Cited by 128
Self-citationTang, Y., Scheef, E. A., Wang, S., Sorenson, C. M., Marcus, C. B., Jefcoate, C. R. E., & Sheibani, N. (2008) · Blood · doi:10.1182/blood-2008-03-145219 · Cited by 128
Michaelis, U. R., & Fleming, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.003 · Cited by 127
Self-citationBlanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126
The Transcriptional Regulation of the Human CYP2C Genes
Chen, Y., & Goldstein, J. A. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375397 · Cited by 125
GROSS, G., Falck, J. R., Gross, E. R., Isbell, M. A., MOORE, J., & Nithipatikom, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.007 · Cited by 125
Coleman, H. A., Tare, M., & Parkington, H. C. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04053.x · Cited by 121
Bidirectional control of arteriole diameter by astrocytes
Gordon, G. R., Howarth, C., & MacVicar, B. A. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053132 · Cited by 118
Saraswathi, V., Hammock, B. D., Newman, J. W. I., Meerarani, P., Toborek, M. J., & Hennig, B. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719328 · Cited by 118
Pokreisz, P., Fleming, I., Kiss, L., Barbosa‐Sicard, E., Fißlthaler, B., Falck, J. R., Hammock, B. D., Kim, I.-H., Szelid, Z., Vermeersch, P., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000208299.62535.58 · Cited by 117
Self-citationUrinary 20-Hydroxyeicosatetraenoic Acid Is Associated With Endothelial Dysfunction in Humans
Ward, N. C., Rivera, J., Hodgson, J. M., Puddey, I. B., Beilin, L. J., Falck, J. R., & Croft, K. D. (2004) · Circulation · doi:10.1161/01.cir.0000136808.72912.d9 · Cited by 116
Zhang, L.-N., Vincelette, J., Cheng, Y., Mehra, U., Chen, D., Anandan, S., Gless, R. D., Webb, H. K., & Wang, Y. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186064 · Cited by 115
Inhibition of Cytochrome P450ω-Hydroxylase
Nithipatikom, K., Gross, E. R., Endsley, M. P., Moore, J. M., Isbell, M. A., Falck, J. R., Campbell, W. B., & Gross, G. J. (2004) · Circulation Research · doi:10.1161/01.res.0000146277.62128.6f · Cited by 115
Potente, M., Michaelis, U. R., Fißlthaler, B., Busse, R., & Fleming, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110806200 · Cited by 114
Self-citationAdventures in vascular biology: a tale of two mediators
Moncada, S. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1775 · Cited by 110
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction
Yasar, ?., Bennet, A. M., Eliasson, E., Lundgren, S., Wiman, B., Fairé, U. D., & Rane, A. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00002 · Cited by 111
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1
Karlgren, M., Gomez, A. V., Stark, K., Svärd, J., Rodríguez‐Antona, C., Oliw, E. H., Bernal, M. L., y Cajal, S. R., Johansson, I., & Ingelman‐Sundberg, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.200 · Cited by 110
Popp, R., Brandes, R. P., Ott, G., Busse, R., & Fleming, I. (2002) · Circulation Research · doi:10.1161/01.res.0000015328.20581.d6 · Cited by 107
Self-citationEndothelium-Derived Hyperpolarizing Factor and Vascular Function
Ozkor, M. A., & Quyyumi, A. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/156146 · Cited by 104
Gomez, G. A., Morisseau, C. H. P., Hammock, B. D., & Christianson, D. W. (2005) · Protein Science · doi:10.1110/ps.051720206 · Cited by 101
The placental pursuit for an adequate oxidant balance between the mother and the fetus
Herrera, E. A., Krause, B. J., Ebensperger, G., Reyes, R. V., Casanello, P. C., Parra-Cordero, M., & Llanos, A. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00149 · Cited by 102
Rifkind, A. B. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570107 · Cited by 97
The emerging role of oxylipins in thrombosis and diabetes
Tourdot, B. E., Ahmed, I., & Holinstat, M. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00176 · Cited by 99
Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Goncharov, N. V., Avdonin, P. V., Nadeev, A. D., Zharkikh, I. L., & Jenkins, R. O. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141014142557 · Cited by 99
Cytochrome P450: major player in reperfusion injury
Gottlieb, R. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.004 · Cited by 96
Mitochondrial dysfunction in glaucoma: Understanding genetic influences
Lascaratos, G., Garway‐Heath, D. F., Willoughby, C. E., Chau, K., & Schapira, A. H. V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.004 · Cited by 97
Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily
Barbosa‐Sicard, E., Markovic, M., Honeck, H., Christ, B., Müller, D. N., & Schunck, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.103 · Cited by 93
The expansive role of oxylipins on platelet biology
Yeung, J., Hawley, M., & Holinstat, M. A. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1542-4 · Cited by 92
Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors
Imig, J. D. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00169.x · Cited by 90
Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death
Posadino, A. M., Cossu, A., Giordo, R., Zinellu, A., Sotgia, S., Vardeu, A., Hoa, P. T., Nguyen, L. H. V., Carru, C., & Pintus, G. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.01.017 · Cited by 90
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics
Imig, J. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.015 · Cited by 89
Nakao, A., Faleo, G., Shimizu, H., Nakahira, K., Kohmoto, J., Sugimoto, R., Choi, A. M. K., McCurry, K. R., Takahashi, T., & Murase, N. (2008) · Kidney International · doi:10.1038/ki.2008.342 · Cited by 88
Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function
Imig, J. D. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.04.003 · Cited by 86
Griffith, T. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.014 · Cited by 85
Imaoka, S., Hashizume, T., & Funae, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.478 · Cited by 83
The molecular sources of reactive oxygen species in hypertension
Puddu, P., Puddu, G. M., Cravero, E., Rosati, M., & Muscari, A. (2008) · Blood Pressure · doi:10.1080/08037050802029954 · Cited by 82
Local Regulation of Microvascular Perfusion
Davis, M. J., Hill, M. A., & Kuo, L. (2008) · Microcirculation · doi:10.1016/b978-0-12-374530-9.00006-1 · Cited by 78
Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids
Rand, A. A., Barnych, B. B., Morisseau, C. H. P., Čajka, T., Lee, K. S. S., Panigrahy, D., & Hammock, B. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616893114 · Cited by 76
Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
Michaud, V., Frappier, M., Dumas, M.-C., & Turgeon, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015666 · Cited by 75
Miller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 76
Chiu, P. Y., & Ko, K. M. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000049151.79238.30 · Cited by 74
Thum, T., & Borlak, J. T. (2003) · Circulation Research · doi:10.1161/01.res.0000110081.03480.e9 · Cited by 73
Rouhanizadeh, M., Hwang, J., Clempus, R. E., Marcu, L., Lassegue, B. P., Sevanian, A., & Hsiai, T. K. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.013 · Cited by 73
Michaelis, U. R., Falck, J. R., Schmidt, R., Busse, R., & Fleming, I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000151648.58516.eb · Cited by 72
Self-citationParkington, H. C., Chow, J. A. M., Evans, R. G., Coleman, H. A., & Tare, M. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021030 · Cited by 71
Soluble Epoxide Hydrolase in Atherosclerosis
Wang, Y.-X. J., Ulu, A., Zhang, L.-N., & Hammock, B. D. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0108-5 · Cited by 70
Estrogen, Aging and the Cardiovascular System
Stice, J. P., Lee, J. S., Pechenino, A. S., & Knowlton, A. A. (2008) · Future Cardiology · doi:10.2217/14796678.5.1.93 · Cited by 70
Ward, N. C., Croft, K. D., Blacker, D., Hankey, G. J., Barden, A. E., Mori, T. A., Puddey, I. B., & Etherton‐Beer, C. (2011) · Clinical Science · doi:10.1042/cs20110215 · Cited by 69
Metadata
- Authors
- Fleming, I.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Fleming, Ingrid
- ORCID
- Fleming, Ingrid
- Venue
- Circulation Research
- Published
- 2001-10-26
- Volume
- 89
- Issue
- 9
- Pages
- 753-762
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2168349092
- Cited by
- 383
- References
- 142
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 8 · 2012: 13
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 553)
- Servier
- Institut de Recherches Servier
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- cytochrome P450, vascular homeostasis, arachidonic acid metabolism, epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, endothelial cells, vascular smooth muscle cells, vasodilation, vasoconstriction, myogenic response, reactive oxygen species, signal transduction, angiogenesis, hypertension, atherosclerosis, cardiovascular disease
- MeSH terms
- Animals, Biological Factors, Cardiovascular System, Cytochrome P-450 Enzyme System, Endothelium, Vascular, Epoxy Compounds, Free Radicals, Homeostasis, Humans, Hydroxyeicosatetraenoic Acids, Mixed Function Oxygenases, Isoenzymes, Muscle, Smooth, Vascular, Vasomotor System, 8,11,14-Eicosatrienoic Acid, Arachidonic Acid, Cytochrome P-450 CYP4A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review